207 related articles for article (PubMed ID: 26759784)
1. Cortical thinning in the anterior cingulate cortex predicts multiple sclerosis patients' fluency performance in a lateralised manner.
Geisseler O; Pflugshaupt T; Bezzola L; Reuter K; Weller D; Schuknecht B; Brugger P; Linnebank M
Neuroimage Clin; 2016; 10():89-95. PubMed ID: 26759784
[TBL] [Abstract][Full Text] [Related]
2. Thalamic-hippocampal-prefrontal disruption in relapsing-remitting multiple sclerosis.
Kern KC; Gold SM; Lee B; Montag M; Horsfall J; O'Connor MF; Sicotte NL
Neuroimage Clin; 2015; 8():440-7. PubMed ID: 26106524
[TBL] [Abstract][Full Text] [Related]
3. Abnormalcortical thickness in relapsing-remitting multiple sclerosis, correlations with cognition impairment, and effect of modified Bushenyisui decoction on cognitive function of multiple sclerosis.
Zhao X; Yang T; Cheng F; Yang S; Zhu W; Li S; Fan Y
J Tradit Chin Med; 2021 Apr; 41(2):316-325. PubMed ID: 33825413
[TBL] [Abstract][Full Text] [Related]
4. Association of Cortical Lesion Burden on 7-T Magnetic Resonance Imaging With Cognition and Disability in Multiple Sclerosis.
Harrison DM; Roy S; Oh J; Izbudak I; Pham D; Courtney S; Caffo B; Jones CK; van Zijl P; Calabresi PA
JAMA Neurol; 2015 Sep; 72(9):1004-12. PubMed ID: 26192316
[TBL] [Abstract][Full Text] [Related]
5. Regional cortical thinning in multiple sclerosis and its relation with cognitive impairment: A multicenter study.
Tillema JM; Hulst HE; Rocca MA; Vrenken H; Steenwijk MD; Damjanovic D; Enzinger C; Ropele S; Tedeschi G; Gallo A; Ciccarelli O; Rovira A; Montalban X; de Stefano N; Stromillo ML; Filippi M; Barkhof F;
Mult Scler; 2016 Jun; 22(7):901-9. PubMed ID: 26432859
[TBL] [Abstract][Full Text] [Related]
6. Evidence for a direct association between cortical atrophy and cognitive impairment in relapsing-remitting MS.
Morgen K; Sammer G; Courtney SM; Wolters T; Melchior H; Blecker CR; Oschmann P; Kaps M; Vaitl D
Neuroimage; 2006 Apr; 30(3):891-8. PubMed ID: 16360321
[TBL] [Abstract][Full Text] [Related]
7. Neocortical volume decrease in relapsing-remitting MS patients with mild cognitive impairment.
Amato MP; Bartolozzi ML; Zipoli V; Portaccio E; Mortilla M; Guidi L; Siracusa G; Sorbi S; Federico A; De Stefano N
Neurology; 2004 Jul; 63(1):89-93. PubMed ID: 15249616
[TBL] [Abstract][Full Text] [Related]
8. Widespread cortical thinning characterizes patients with MS with mild cognitive impairment.
Calabrese M; Rinaldi F; Mattisi I; Grossi P; Favaretto A; Atzori M; Bernardi V; Barachino L; Romualdi C; Rinaldi L; Perini P; Gallo P
Neurology; 2010 Jan; 74(4):321-8. PubMed ID: 20101038
[TBL] [Abstract][Full Text] [Related]
9. Contribution of cortical and white matter lesions to cognitive impairment in multiple sclerosis.
Papadopoulou A; Müller-Lenke N; Naegelin Y; Kalt G; Bendfeldt K; Kuster P; Stoecklin M; Gass A; Sprenger T; Radue EW; Kappos L; Penner IK
Mult Scler; 2013 Sep; 19(10):1290-6. PubMed ID: 23459568
[TBL] [Abstract][Full Text] [Related]
10. Cortical lesions and atrophy associated with cognitive impairment in relapsing-remitting multiple sclerosis.
Calabrese M; Agosta F; Rinaldi F; Mattisi I; Grossi P; Favaretto A; Atzori M; Bernardi V; Barachino L; Rinaldi L; Perini P; Gallo P; Filippi M
Arch Neurol; 2009 Sep; 66(9):1144-50. PubMed ID: 19752305
[TBL] [Abstract][Full Text] [Related]
11. Executive functioning affects verbal learning process in multiple sclerosis patients: Behavioural and imaging results.
Pitteri M; Dapor C; Pisani AI; Castellaro M; DeLuca J; Chiaravalloti N; Guandalini M; Ziccardi S; Calabrese M
J Neuropsychol; 2020 Sep; 14(3):384-398. PubMed ID: 31785082
[TBL] [Abstract][Full Text] [Related]
12. Predicting clinical progression and cognitive decline in patients with relapsing-remitting multiple sclerosis: a 6-year follow-up study.
Kania K; Pawlak MA; Forycka M; Wiłkość-Dębczyńska M; Michalak S; Łukaszewska A; Wyciszkiewicz A; Wypych A; Serafin Z; Marcinkowska J; Kozubski W; Kalinowska-Łyszczarz A
Neurol Neurochir Pol; 2024; 58(2):176-184. PubMed ID: 38324117
[TBL] [Abstract][Full Text] [Related]
13. The association between intra- and juxta-cortical pathology and cognitive impairment in multiple sclerosis by quantitative T
Louapre C; Govindarajan ST; Giannì C; Madigan N; Nielsen AS; Sloane JA; Kinkel RP; Mainero C
Neuroimage Clin; 2016; 12():879-886. PubMed ID: 27872810
[TBL] [Abstract][Full Text] [Related]
14. Thalamic atrophy predicts cognitive impairment in relapsing remitting multiple sclerosis. Effect on instrumental activities of daily living and employment status.
Papathanasiou A; Messinis L; Zampakis P; Panagiotakis G; Gourzis P; Georgiou V; Papathanasopoulos P
J Neurol Sci; 2015 Nov; 358(1-2):236-42. PubMed ID: 26359854
[TBL] [Abstract][Full Text] [Related]
15. Brain atrophy as a marker of cognitive impairment in mildly disabling relapsing-remitting multiple sclerosis.
Sánchez MP; Nieto A; Barroso J; Martín V; Hernández MA
Eur J Neurol; 2008 Oct; 15(10):1091-9. PubMed ID: 18727673
[TBL] [Abstract][Full Text] [Related]
16. Thalamic atrophy and cognitive impairment in clinically isolated syndrome and multiple sclerosis.
Štecková T; Hluštík P; Sládková V; Odstrčil F; Mareš J; Kaňovský P
J Neurol Sci; 2014 Jul; 342(1-2):62-8. PubMed ID: 24819917
[TBL] [Abstract][Full Text] [Related]
17. Predicting cognitive decline in multiple sclerosis: a 5-year follow-up study.
Eijlers AJC; van Geest Q; Dekker I; Steenwijk MD; Meijer KA; Hulst HE; Barkhof F; Uitdehaag BMJ; Schoonheim MM; Geurts JJG
Brain; 2018 Sep; 141(9):2605-2618. PubMed ID: 30169585
[TBL] [Abstract][Full Text] [Related]
18. Association between symbol digit modalities test and regional cortex thickness in young adults with relapsing-remitting multiple sclerosis.
Tao Y; XueSong Z; Xiao Y; YueZhi K; Xin W; YanPing T; Lei W; YongPing F
Clin Neurol Neurosurg; 2021 Aug; 207():106805. PubMed ID: 34280674
[TBL] [Abstract][Full Text] [Related]
19. Cortical and Subcortical Morphometric and Iron Changes in Relapsing-Remitting Multiple Sclerosis and Their Association with White Matter T2 Lesion Load : A 3-Tesla Magnetic Resonance Imaging Study.
Al-Radaideh A; Athamneh I; Alabadi H; Hbahbih M
Clin Neuroradiol; 2019 Mar; 29(1):51-64. PubMed ID: 29299614
[TBL] [Abstract][Full Text] [Related]
20. Lesion probability mapping to explain clinical deficits and cognitive performance in multiple sclerosis.
Kincses ZT; Ropele S; Jenkinson M; Khalil M; Petrovic K; Loitfelder M; Langkammer C; Aspeck E; Wallner-Blazek M; Fuchs S; Jehna M; Schmidt R; Vécsei L; Fazekas F; Enzinger C
Mult Scler; 2011 Jun; 17(6):681-9. PubMed ID: 21177325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
